Hcv vaccines
OwnerMichael Buschle, Jürgen Frisch +4inventors
InventorsMichael Buschle, Jürgen Frisch, Christoph Klade, Karen Lingnau, Wolfgang Zauner, Gerd Zettlmeissl
Life of this patent
Estimating the term…
Abstract
Disclosed are methods and compositions for inducing immune responses against Hepatatis C virus (HCV). The compositions comprise one or more epitope from a hotspot epitope. In certain embodiments, an HCV vaccine comprising at least two epitopes, each from a different hotspot epitope, is provided.
Claims12
1-51. (canceled)
A hepatitis C virus (HCV) vaccine comprising GYKVLVLNPSVAAT (SEQ ID NO:60), HMWNFISGIQYLAGLSTLPGNPA (SEQ ID NO:63), CINGVCWTV (SEQ ID NO:17), DLMGYIPAV (SEQ ID NO:19), KFPGGGQIVGGVYLLPRRGPRL (SEQ ID NO:72), and polyarginine.
53-54. (canceled)
63-64. (canceled)
Dependencies are inferred from the claim text.